Stem Cell Therapy for Infertility Market Growth Outlook Through 2030

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Does The Market Size Of The Stem Cell Therapy For Infertility Market Compare Between 2026 And 2030?

The stem cell therapy for infertility market size has seen rapid expansion in recent years. It is anticipated to increase from $1.87 billion in 2025 to $2.18 billion in 2026, at a compound annual growth rate (CAGR) of 16.6%. This historical growth can be attributed to the rising prevalence of infertility conditions, the global expansion of fertility clinics, advancements in reproductive biology research, growing demand for alternative infertility treatments, and the increased adoption of assisted reproductive procedures.

The stem cell therapy for infertility market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $3.99 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 16.4%. Factors contributing to this growth over the forecast period include enhanced clinical validation of stem cell treatments for infertility, greater investments in reproductive regenerative medicine, a growing embrace of personalized fertility approaches, an increase in clinical trials focused on reproductive health, and stronger partnerships between fertility clinics and research organizations. Key trends expected during the forecast period encompass a heightened emphasis on therapies for ovarian and testicular regeneration, a rise in the application of autologous stem cell treatments, increasing incorporation with assisted reproductive technologies, the broadening of personalized fertility treatment protocols, and intensified clinical research within reproductive regeneration.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30408&type=smp

What Significant Factors Are Influencing The Stem Cell Therapy For Infertility Market Expansion?

The escalating instances of infertility are projected to notably contribute to the expansion of the stem cell therapy for infertility market moving forward. Infertility is characterized as a couple’s inability to conceive after 12 months or more of regular unprotected sexual intercourse. The rising occurrence of infertility is largely ascribed to delayed childbearing, as many individuals opt to have children later in life, resulting in diminished fertility due to the natural decline in reproductive potential with age, particularly among women. Stem cell therapy for infertility offers promising remedies by regenerating impaired reproductive tissues, enhancing ovarian and testicular function, and boosting the likelihood of conception. For instance, in April 2023, a report from the World Health Organization (WHO), a Switzerland-based intergovernmental organization, revealed that infertility impacts approximately 17.5% of the adult population, or about 1 in 6 people globally, emphasizing the growing necessity to broaden access to affordable and high-quality fertility care. Hence, the increasing cases of infertility are expected to fuel the growth of the stem cell therapy for infertility market.

How Are Segments Identified Within The Stem Cell Therapy For Infertility Market Segment Framework?

The stem cell therapy for infertility market covered in this report is segmented –

1) By Type: Male Infertility Treatment, Female Infertility Treatment

2) By Treatment Type: Autologous Stem Cell Therapy, Allogeneic Stem Cell Therapy, Combination Therapy

3) By Cell Source: Embryonic Stem Cells, Adult Stem Cells, Induced Pluripotent Stem Cells

4) By Application: Ovarian Insufficiency, Uterine Infertility, Genetic Disorders

5) By End User: Hospitals, Specialty Clinics, Research Institutes

Subsegments:

1) By Male Infertility Treatment: Surgical Sperm Retrieval, Hormonal Therapy, Stem Cell Transplantation, Assisted Reproductive Techniques

2) By Female Infertility Treatment: Ovarian Stem Cell Therapy, Endometrial Regeneration Therapy, Hormonal Therapy, In Vitro Fertilization Enhancement

What Trends Are Affecting The Direction Of The Stem Cell Therapy For Infertility Market?

Major companies operating in the stem cell therapy for infertility market are concentrating on innovations in stem cell technologies, including induced pluripotent stem cells (iPSCs), with the aim of advancing personalized regenerative treatments, improving patient-specific results, and broadening the spectrum of treatable reproductive conditions. Induced pluripotent stem cells are adult somatic cells that have been genetically altered to achieve an embryonic-like pluripotent state, enabling their differentiation into virtually any cell type within the body. As an example, in January 2025, Gameto Inc., a US-based biotechnology company, commenced a pivotal Phase III clinical trial for its iPSC-derived fertility therapy, Fertilo, following Investigational New Drug (IND) approval from the U.S. Food and Drug Administration (FDA). This trial, which is being conducted at approximately 15 sites across the U.S., intends to evaluate egg maturation outside the body using engineered ovarian support cells, which could potentially shorten IVF cycles and decrease hormonal stimulation by up to 80%. If successful, this initiative will represent the first late-stage clinical program for an in-vitro matured egg therapy derived from induced pluripotent stem cells in the treatment of infertility.

Who Are The Companies Competing Within The Stem Cell Therapy For Infertility Market?

Major companies operating in the stem cell therapy for infertility market are PlacidWay LLC, New Life India Fertility Clinic Private Limited, Jeevan Mithra Fertility Centre Private Limited, Equipo IVI S.L., Hope Fertility & Stem Cell Centre Pvt. Ltd., Bioscience Institute SpA, Advancells Dermaceuticals Private Limited, GIOSTAR INDIA PRIVATE LIMITED, Shree IVF Clinic Private Limited, Stem Cells Care (india) Private Limited, GenCell Ltd., StemRx BioScience Solutions Private Limited., Kiran Infertility Centre Private Limited, R3 Stem Cell LLC., Bavishi Fertility Institute Private Limited, Seragen Biotherapeutics Private Limited, Esha IVF Fertility Centre Private Limited, Embryonic Tissue Center EmCell, InoCells B.V., Vega Stem Cell Clinic Co. Ltd.

Get The Full Stem Cell Therapy For Infertility Market Report:

https://www.thebusinessresearchcompany.com/report/global-stem-cell-therapy-for-infertility-market-report

Which Region Accounts For The Largest Portion Of The Stem Cell Therapy For Infertility Market?

North America was the largest region in the stem cell therapy for infertility market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the stem cell therapy for infertility market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Stem Cell Therapy For Infertility Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/global-stem-cell-therapy-for-infertility-market-report

Browse Through More Reports Similar to the Global Stem Cell Therapy For Infertility Market 2026, By The Business Research Company

Stem Cells Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

Fertility Drugs Market Report

https://www.thebusinessresearchcompany.com/report/fertility-drugs-global-market-report

Fertility Treatments Market Report

https://www.thebusinessresearchcompany.com/report/fertility-treatments-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795